Trial Profile
Second Generation Low Molecular Weight Heparin (Bemiparin) as a Prophylactic for Management of Subsequent Pregnancy After an Unexplained Stillbirth: A Clinical Comparative Study
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 17 Dec 2018
Price :
$35
*
At a glance
- Drugs Bemiparin sodium (Primary)
- Indications Pregnancy complications
- Focus Therapeutic Use
- 07 Dec 2018 Status changed from recruiting to completed.
- 01 Aug 2018 New trial record